Mark E. Dovey, MD

Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan M, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin P, Ramsey B, and the Cystic Fibrosis Therapeutics Development Network Study Group. Significant microbiologic effect of inhaled tobramycin in young children with cystic fibrosis. Am J of Resp and Crit Care Med 2003; 167(6): 841-849.

Coumeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O’Sullivan BP, Waltz DA, Zwerdling R, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 2003; 113(6):1573-1581.

Comeau AM, Parad R, Gerstle R, O’Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result. J Pediatr. 2005 Sep;147(3 Suppl):S98-100.

Comeau AM, Parad R, Gerstle R, O’Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Challenges in implementing a successful newborn cystic fibrosis screening program. J Pediatr. 2005 Sep;147(3 Suppl):S89-93.

Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O’Sullivan BP. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr. 2005 Sep;147(3 Suppl):S69-72.

Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, Lipuma JJ, Gerard C, Goldmann D. Impact of Burkholderia Dolosa on Lung Function and Survival in Cystic Fibrosis. Am J Respir Crit Care Med. 2006; 173: 421-425.

Dovey M, Aitken M, Emerson J, McNamara S, Waltz DA, Gibson RL. Oral corticosteroid therapy in cystic fibrosis patients hospitalized for a pulmonary exacerbation: a pilot study. Chest 2007; 132: 1212-1218.

Aitken ML, Bellon G, De Boeck K, Flume PA, Fox HG, Geller DE, Haarman EG, Hebestreit HU, Lapey A, Schou IM, Zuckerman JB, Charlton B; Alais ME, Bonina AJ, Ditondo JC, Lentini E, Marques I, Pinero R, Segal E, Teper A, Lyttle B, Michael R, Rabin H, Casimir G, DeBoeck C, Deseger K, Malfroot A, Bellon G, Bremont F, David V, Dubus JC, Durieu I, Foucaud P, Kessler R, Leroy S, Marguet C, Munck A, Turck D, Weiss L, Fischer R, Hebestreit H, Nahrlich L, Reithmuller J, Haarman E, Merkus P, Aitken M, Barnett B, Borowitz D, Daines C, Dovey M, Flume P, Fornos P, Froh D, Geller D, Jain M, Jones K, Konig P, Lapey A, Lapin C, McWilliams B, Meyer K, Murphy P, Oermann C, Royall J, Rulon E, Salathe M, Schaeffer D, Schoumacher R, Wallace J, Willey-Courand DB, Williams R, Zeitlin P, Zuckerman J. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study. Am J Respir Crit Care Med. 2012 Mar15; 185(6):645-652.

Sheares BJ, Mellins RB, Dimango E, Serebrisky D, Zhang Y, Bye MR, Dovey ME, Nachman S, Hutchinson V, Evans D. Do patients of subspecialist physicians benefit from written asthma action plans? Am J Respir Crit Care Med. 2015 June 15;191(2): 1374-83.

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; Gibson R, Rowe S, Boyle M, Clancy J, Donaldson S, Moss R, Walker S, Powers M, Escobar H, Berdella M, Froh D, Vender R, Fracchia M, McColley S, Moffett K, Nasr S, Taylor-Cousar J, Rogers J, Shay G, Brown P, Dorkin H, Zanni R, Fink R, Omlor G, Meyer K, Naureckas E, Worth H, Roberts D, Whittaker-LeClair L, Dozor A, Rao A, Rolfe M, Amaro-Galvez R, Berlinski A, Calimano F, Chin T, Conrad D, Daines C, Epstein C, Green D, Ischander M, Keens T, Lascano J, Martinez J, McWilliams B, Sauder A, Stone A, Sudhakar R, Weatherly M, Ludwig B, Ratjen F, Tullis E, Chilvers M, Michael R, Aaron S, Hebestreit H, Zimmermann T, Drevinek P, Staab D, Bittenglova R, Homola L, Riethmueller J, van Koningsbrugge S, Wirtz H, Doney D, Carroll M, Nash E, Withers N, Smyth A, Rault G, Hubert D, Sermet-Gaudelus I, Bakker M, Reix P, Durieu I, Weiss L, Heijerman H, Merkus P, Weersink E, McNally P, McKone E, Greally P, Selvadurai H, Greville H, Middleton P, Wark P, Braggion C, Cipolli M, Colombo C, Gagliardini R, Lucidi V, Minicucci L, Quattrucci S, Hjelte L, Hollsing A, Gilljam M, Ahrens R, McCoy K, Aitken M, Konstan M, Pilewski J, Billings J, Rubenstein R, Faro A, Anbar R, Frederick C, Liou T, Colombo J, Montgomery G, Anstead M, Millard S, Miller A, Barto T, Biller J, Vauthy P, Zuckerman J, Rosen J, Schultz K, DiMango E, Fiel S, Flume P, Ren C, Royall J, Salathe M, Schmidt H, Lapin C, Stokes D, Dovey M, O'Sullivan B, Accurso F, Cannon C, McCarthy M, Kissner D, McNamara J, Heidarian-Raissy H, Egan M, Hardy K, Hoag J, Majure JM, Mermis J, Morrissey B, Reyes De La Rocha S, Scanlin T, Schaeffer D, Sepulveda P, Wallace J, Wooldridge J, Wilcox P, Lands L, Rabin H, Brown N, Tuemmler B, Griese M, Mainz J, Ballmann M, Gleiber W, Pressler T, Huber R, Naehrlich L, Fischer R, Davies J, Doe S, Hilliard T, Pecham D, Walshaw M, Lee T, Munck A, De Boeck K, Chiron R, Bobolie H, De Baets F, Knoop C, Bremont F, Fayon M, Reynaud-Gaubert M, Wizla N, Gartner S, Jover AS, Roldan Jde G, Serisier D, Wainwright C, Bell S, Thompson P, Clements B, Ellemunter H, Feizelmeier H.Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med. 2015 Jul 16; 373(3):220-31.

Rice J, Matlack KM, Simmons M, Steinfeld J, Laws MA, Dovey ME, Cohen RT. LEAP: A randomized-controlled trial of a lay-educator inpatient asthma education program. Patient Educ Couns. 2015 June 29; 98(12):1585-1591.

Full Publication List via NIH PubMed »